These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 555032)

  • 1. [Induced platelet aggregation as a fitness test for blood donors: preliminary study].
    Tordato G; Valbonesi M; Mosconi L; Florio G
    Riv Emoter Immunoematol; 1979; 26(3-4):130-7. PubMed ID: 555032
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of lipid peroxidation-modified lipoproteins on thrombocyte aggregation].
    Azizova OA; Vlasova II
    Biull Eksp Biol Med; 1993 Nov; 116(11):485-7. PubMed ID: 8312535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for selective degradation of platelet GP IIb/IIIa complex after prolonged in vitro ventricular assist.
    Serna DL; King BO; Huh J; Jalal R; Tran L; Chen JC
    J Investig Med; 1998 Aug; 46(6):279-83. PubMed ID: 9737089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet function in whole-blood donors is impaired: the effects of painkillers.
    Curvers J; Dielis AW; Heeremans J; van Wersch JW
    Transfusion; 2007 Jan; 47(1):67-73. PubMed ID: 17207232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanoparticles and a microscopic view of platelets: a preliminary observation.
    Wiwanitkit V; Sereemaspun A; Rojanathanes R
    Cardiovasc J Afr; 2009; 20(2):141-2. PubMed ID: 19421652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of triofen on platelet aggregation].
    Tulupov AN; Filev LV; Belskikh AN; Medvedev IuV; Popov VG
    Biull Eksp Biol Med; 1990 Oct; 110(10):395-6. PubMed ID: 2279091
    [No Abstract]   [Full Text] [Related]  

  • 8. [Platelet aggregation and bloodletting in normal subjects].
    Cordova C; Musca A; Perrone A; Violi F; Marigliano V
    Boll Soc Ital Biol Sper; 1978 Feb; 53(24):2477-9. PubMed ID: 637946
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia.
    Chong BH; Burgess J; Ismail F
    Thromb Haemost; 1993 Apr; 69(4):344-50. PubMed ID: 8497847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudothrombocytopenia in blood donors.
    Maslanka K; Marciniak-Bielak D; Szczepinski A
    Vox Sang; 2008 Nov; 95(4):349. PubMed ID: 19138266
    [No Abstract]   [Full Text] [Related]  

  • 11. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)].
    Shenkman B; Einav Y; Salomon O; Varon D; Savion N
    Platelets; 2008 Sep; 19(6):440-6. PubMed ID: 18925512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction.
    Jámbor C; Weber CF; Gerhardt K; Dietrich W; Spannagl M; Heindl B; Zwissler B
    Anesth Analg; 2009 Jul; 109(1):25-31. PubMed ID: 19439684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooled donor control for platelet aggregometry.
    Abernathy L; Hill J; Hutchinson D
    Thromb Haemost; 1978 Feb; 39(1):246-7. PubMed ID: 580502
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals.
    Seyfert UT; Haubelt H; Vogt A; Hellstern P
    Platelets; 2007 May; 18(3):199-206. PubMed ID: 17497431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma components which interfere with ristocetin-induced platelet aggregation.
    Baugh RF; Brown JE; Hougie C
    Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study.
    Scharbert G; Kalb M; Marschalek C; Kozek-Langenecker SA
    Anesth Analg; 2006 Apr; 102(4):1280-4. PubMed ID: 16551937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation.
    Matera C; Falzarano C; Vacca C; Falciani M; Rossi F
    J Med; 1994; 25(1-2):2-16. PubMed ID: 7930957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the platelet concentrate obtained with the MCS cell separator of the Society of Haemonetics].
    Schooneman F
    Ann Med Interne (Paris); 1994; 145(5):345-9. PubMed ID: 7985946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.